Joseph C. Abeles serves as Executive at IGENE BIOTECHNOLOGY INC, where they oversee executive responsibilities. Since joining the company, Joseph C. Abeles has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 23, 2006 involved exercising options for 14,750 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 23, 2006 | IGNE | $0 | Conversion | 14,750 | $N/A | Discretionary |
Joseph C. Abeles currently holds 2,128,294 shares of IGENE BIOTECHNOLOGY INC (IGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph C. Abeles has been a net neutral trader of IGNE stock. They have purchased $0 and sold $0 worth of shares.
Joseph C. Abeles's most recent insider trade was on Mar 23, 2006, when they sold 14,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted